Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 6975-6980

  Asanuma, Hideki ^a,b,c   Fujihashi, Kohtaro ^c   Miyakoshi, Takashi ^a   Yoshikawa, Tomoki ^b   Fujita Yamaguchi, Yoko ^a   Kojima, Naoya ^a   Nakata, Munehiro ^a   Suzuki, Yujiro ^d   Tamura, Shin ichi ^b   Kurata, Takeshi ^b   Sata, Tetsutaro ^b  

^a TOKAI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d KITASATO INSTITUTE   (Japan)

Author keywords

Adjuvant; Aged mice; Influenza vaccine; Mucosal immunity; Nasal IgA

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ADJUVANT THERAPY; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INFLUENZA; INFLUENZA VIRUS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; AGING; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SPECIES SPECIFICITY; TIME FACTORS;

EID: 34548599777     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.060     Document Type: Article

References (23)

1. Gibbson J.H. Summary of medical literature: review of effectiveness of inactivated influenza virus vaccine. Cost effectiveness of influenza vaccination (1981), Office of Technology Assessment, Washington DC [pp. 43-45]
2. Brandriss M.W., Betts R.F., Mathur U., and Douglas R.G. Responses of elderly subjects to monovalent A/USSR/77(H1N1) and trivalent A/USSR/77(H1N1)-A/Texas/77(H3N2) -B/Hong Kong/72 vaccines. Am Rev Resp Dis 124 (1981) 681-684
3. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., and Levandowski R.A. The efficacy of influenza vaccines in elderly persons: a meta-analysis and review of the literature. Ann Int Med 123 (1995) 518-527
4. Arden N.H., Patriarca P.A., and Kendal A.P. Options for the control of influenza (1986), AR Liss, NY [pp. 155-168]
5. Ghendon Y. The immune response of humans to live and inactivated influenza vaccines. Adv Exp Med Biol 257 (1989) 37-45
6. Small Jr. P.A. Influenza: pathogenesis and host defense. Hosp Pract 25 51-54 (1990) 57-62
7. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., and Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 14 (1984) 350-356
8. Tamura S.-I., Samegai Y., Kurata H., Nagamine T., Aizawa C., and Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 6 (1988) 409-413
9. Tamura S.-I., Yamanaka A., Shimohara M., Tomita T., Komase K., Tsuda Y., et al. Synergistic action of cholera toxin B subunit (and E. coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12 (1994) 419-426
10. Hirabayashi Y., Tamura S.I., Suzuki Y., Nagamine T., Aizawa C., Shimada K., et al. H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. Immunology 72 (1991) 329-335
11. Yoshikawa T., Suzuki Y., Nomoto A., Sata T., Kurata T., and Tamura S.-I. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase. Vaccine 21 (2002) 60-66
12. Matsuo K., Yoshikawa T., Asanuma H., Iwasaki T., Hagiwara Y., Chen Z., et al. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine 18 (2000) 2713-2722
13. Tamura S.-I., Funato H., Nagamine T., Aizawa C., and Kurata T. Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CT-B. Vaccine 7 (1989) 503-505
14. Tamura S.-I., Yajima A., Hatori E., Tamura S., Asanuma H., Suzuki Y., et al. Effect of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against infection. Vaccine 15 (1997) 1784-1790
15. Asanuma H., Hirokawa K., Uchiyama M., Suzuki Y., Aizawa C., Kurata T., et al. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine 19 (2001) 3981-3989
16. Tamura S.-I., Ito Y., Asanuma H., Hirabayashi Y., Suzuki Y., Nagamine T., et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149 (1992) 981-988
17. Asanuma H., Inaba Y., Aizawa C., Kurata T., and Tamura S.-I. Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Methods 187 (1995) 41-51
18. Tamura S.-I., Asanuma H., It Y., Hirabayashi Y., Suzuki Y., Nagamine T., et al. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza HA vaccine. Eur J Immunol 22 (1992) 477-481
19. Tamura S., Yajima A., Hatori E., Tamura S., Asanuma H., Suzuki Y., et al. Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection. Vaccine 15 (1997) 1784-1790
20. Elson C.O., and Ealding W. Genetic control of the murine immune response to cholera toxin. J Immunol 135 (1985) 930-932
21. Hashigucci K., Ogawa H., Ishidate T., Yamashita R., Kamiya H., Watanabe K., et al. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 14 (1996) 113-119
22. Hashigucci K., Tamura S., Kurata T., Kamiya H., and Ishidate T. Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers. J Jpn Assoc Infect Dis 71 (1997) 153-161
23. Tamura S.-I., Tanimoto T., and Kurata T. Mechanisms of broad cross-protection by influenza virus infection and their application to vaccines. Jpn J Infect Dis 58 (2005) 195-207